Literature DB >> 9786440

Reliability and validity of the Mini PAS-ADD for assessing psychiatric disorders in adults with intellectual disability.

H Prosser1, S Moss, H Costello, N Simpson, P Patel, S Rowe.   

Abstract

The Mini PAS-ADD is an assessment schedule for psychiatric disorders in people with an intellectual disability. It is designed to provide a link between the mental health expertise of psychiatrists and psychologists, and the detailed knowledge of individual service users possessed by support staff. In broad terms, the aim of the Mini PAS-ADD is to enable non-psychiatrists accurately to recognize clinically significant psychiatric disorders in the people who they care for, so that they can make informed referral decisions. The instrument comprises 86 psychiatric symptoms and generates a series of subscores on: depression, anxiety and phobias, mania, obsessive-compulsive disorder, psychosis, unspecified disorder (including dementia), and pervasive developmental disorder (autism). The present paper reports the results of a study investigating internal consistency, inter-rater agreement and validity in relation to clinical opinion, using a sample of 68 people with intellectual disability who were in contact with psychiatric services. In terms of the instrument fulfilling its main intended function, i.e. accurate case recognition, the crucial question was whether the support workers, with their lesser knowledge of psychopathology, were also able to correctly identify cases identified by expert clinicians. The validity results in this respect (81% agreement on case recognition) were sufficiently good that it is to be anticipated that the Mini PAS-ADD should have a significant impact on the identification of psychiatric disorders in the community of people with intellectual disability.

Entities:  

Mesh:

Year:  1998        PMID: 9786440     DOI: 10.1046/j.1365-2788.1998.00146.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  22 in total

1.  Developmental level and other factors associated with symptoms of mental disorders and problem behaviour in adults with intellectual disabilities living in the community.

Authors:  Oddbjørn Hove; Odd E Havik
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-05       Impact factor: 4.328

2.  Psychiatric comorbidity and medication use in adults with autism spectrum disorder.

Authors:  Tara R Buck; Joseph Viskochil; Megan Farley; Hilary Coon; William M McMahon; Jubel Morgan; Deborah A Bilder
Journal:  J Autism Dev Disord       Date:  2014-12

3.  The use of two different MLPA kits in 22q11.2 deletion syndrome.

Authors:  L J M Evers; J J M Engelen; L M H Houben; L M G Curfs; T A M J van Amelsvoort
Journal:  Eur J Med Genet       Date:  2016-02-24       Impact factor: 2.708

4.  Mental illness, problem behaviour, needs and service use in adults with intellectual disability.

Authors:  Matthias Schützwohl; Andrea Koch; Nadine Koslowski; Bernd Puschner; Elke Voß; Hans Joachim Salize; Andrea Pfennig; Anke Vogel
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-03-07       Impact factor: 4.328

5.  Inter-Rater Reliability of the Diagnoses of Psychosis and Depression in Individuals with Intellectual Disabilities.

Authors:  S Einfeld; B Tonge; L Chapman; C Mohr; J Taffe; S Horstead
Journal:  J Appl Res Intellect Disabil       Date:  2007-09

Review 6.  Anxiety disorders in persons with developmental disabilities: empirically informed diagnosis and treatment. Reviews literature on anxiety disorders in DD population with practical take-home messages for the clinician.

Authors:  Ervin Davis; Sy Atezaz Saeed; Diana J Antonacci
Journal:  Psychiatr Q       Date:  2008-08-23

Review 7.  Mental health disorders among individuals with mental retardation: challenges to accurate prevalence estimates.

Authors:  Bonnie D Kerker; Pamela L Owens; Edward Zigler; Sarah M Horwitz
Journal:  Public Health Rep       Date:  2004 Jul-Aug       Impact factor: 2.792

Review 8.  Diagnosis and treatment of aggression in individuals with developmental disabilities.

Authors:  Diana J Antonacci; Crystal Manuel; Ervin Davis
Journal:  Psychiatr Q       Date:  2008-08-23

9.  Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.

Authors:  Omri Weisman; Yael Guri; Raquel E Gur; Donna M McDonald-McGinn; Monica E Calkins; Sunny X Tang; Beverly Emanuel; Elaine H Zackai; Stephan Eliez; Maude Schneider; Marie Schaer; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Vandana Shashi; Stephen R Hooper; Marco Armando; Stefano Vicari; Maria Pontillo; Leila Kushan; Maria Jalbrzikowski; Carrie E Bearden; Joseph F Cubells; Opal Y Ousley; Elaine F Walker; Tony J Simon; Joel Stoddard; Tara A Niendam; Marianne B M van den Bree; Doron Gothelf
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

Review 10.  Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Authors:  Maude Schneider; Martin Debbané; Anne S Bassett; Eva W C Chow; Wai Lun Alan Fung; Marianne van den Bree; Michael Owen; Kieran C Murphy; Maria Niarchou; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Donna M McDonald-McGinn; Raquel E Gur; Elaine H Zackai; Jacob Vorstman; Sasja N Duijff; Petra W J Klaassen; Ann Swillen; Doron Gothelf; Tamar Green; Abraham Weizman; Therese Van Amelsvoort; Laurens Evers; Erik Boot; Vandana Shashi; Stephen R Hooper; Carrie E Bearden; Maria Jalbrzikowski; Marco Armando; Stefano Vicari; Declan G Murphy; Opal Ousley; Linda E Campbell; Tony J Simon; Stephan Eliez
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.